Fir | Caring Sunshine

Other Names

abete balsamicoabeto balsamicoabeto olorosoAbiesAbies albaAbies amabilisAbies baldensisAbies balsameaAbies candicansAbies concolorAbies fraseriAbies grandisAbies koreanaAbies lasiocarpaAbies lowianaAbies magnificaAbies nobilisAbies nordmannianaAbies proceraAbies sibiricaAbies sibirica Ledeb.Abies Sibirica Needle OilAbies spp.alpine firbalm-of-gileadbalm-of-gilead firbalsam firbalsam of firbalsam-granbalsam-tannebalsem-denbalsemzilver-denbeaumier de Gileadblister firblister pinebracted balsam firCalifornia white firCanada balsamCanada turpentineCanadian balsamCanadian firCaucasian fircommon fircommon silver fireastern firEuropean silver firfir balsamfir needlefir needle oilfir pinefir-treefirs d'americaFraser firFraser's firGilead firgrand firKorean firnoble firNordmann firOleum Pini SibiricumPacific silver firPinaceaeRocky Mountain white firsapinsapin baumiersapin beaumiersapin blancsapin rougeshe-balsamSiberian firsilver firsilver pinesingle pinesingle sprucesouthern balsam firsouthern firtrue firTurkish firwhite fir

Synopsis

Fir (Abies spp.): A Comprehensive Encyclopedic Reference

1. Identity: Botanical Classification, Species, and Common Forms

Taxonomy and Principal Species

The genus Abies (family Pinaceae) was first formally described by Philipp Miller (1691–1771) in 1754 and is considered the second-largest genus of the family Pinaceae, with all its taxa natively distributed throughout the Northern Hemisphere. The genus Abies is estimated to comprise 52 species with accepted status, to which 58 other species whose status has not yet been ascertained must be added. Among the species of medicinal and dietary supplement relevance:

Abies alba Mill. — European silver fir. A widespread gymnosperm species in Europe, important for its ecological, economic, social, and cultural significance, as well as for its use for food and bioremediation purposes.
Abies balsamea (L.) Mill. — Balsam fir. Also called Canada turpentine or balsam of fir, this tree produces an oleoresin native to boreal North America.
Abies amabilis Douglas ex J.Forbes — Pacific silver fir, native to the Pacific Northwest of North America.
Abies spectabilis (D.Don) Spach — Himalayan silver fir, native to the Himalayan region.
Abies koreana E.H.Wilson — Korean fir, a species studied for its essential oil composition.

The correct botanical name for the European silver fir is Abies alba Mill. Abies alba (silver fir) is chemically distinct from Abies concolor (true white fir), though both are sold under "white fir" in some markets. Abies alba belongs to the fir genus, not pine, within the family Pinaceae. Accurate use of the botanical name is important to prevent misidentification in both research and commerce.

Plant Parts Used and Common Preparations

The various parts of the plant — leaves, branches, cones, wood, and bark — are all of pharmaceutical interest due to their composition of active compounds. The principal preparations used as dietary supplements or in traditional and modern herbal medicine include:

Essential oil: Obtained primarily by steam distillation or hydrodistillation of needles, twigs, or bark. Most parts of the Abies alba tree contain essential oils with similar but not identical compositions and production yields, the major compounds being monoterpene hydrocarbons.
Oleoresin (balsam/turpentine): Canada balsam (from Abies balsamea) is a viscous oleoresin — technically a mixture of resin and essential oils, not a true balsam — exuded from blisters on the bark of the tree. Strasbourg turpentine is obtained from Abies alba and is named after the trading center in the Vosges; it is a less viscous balsam that was used historically as a varnish and also as an ingredient in oil varnishes.
Standardized polyphenolic bark and wood extracts: Commercial preparations including Abigenol® (bark extract) and Belinal® (branch/wood extract) are aqueous extracts of Abies alba fractionated with ethyl acetate. Belinal® is an industrially manufactured polyphenolic extract derived from A. alba branches, with in vitro antioxidant effects similar to those of epigallocatechin gallate and superior to those of resveratrol, ascorbic acid, or butylated hydroxytoluene; it is the ethyl acetate-soluble fraction of an extract prepared with water at 70°C for 2 hours. Abigenol® is another extract obtained with water in a similar manner but from bark at 70°C.
Infusions and decoctions: Prepared from needles, buds, or bark for traditional medicinal use.
Topical preparations: Bath extracts, rubbing oils, and salves incorporating resin or essential oil.

2. Traditional and Historical Use

Indigenous North American Use (Balsam Fir, Abies balsamea)

Indigenous peoples of North America, particularly the Ojibwe (including the Pillager and Flambeau bands), have long utilized the resin from balsam fir for medicinal purposes. The Pillager Ojibwe applied the balsam gum topically as a salve to heal sores and internally for colds, while the Flambeau Ojibwe used it to treat cuts, bruises, and sore eyes by extracting it directly from bark blisters. Other First Nations, such as the Algonquin and Cree, employed the resin as an antiseptic poultice for burns and wounds, leveraging its antimicrobial properties to prevent infection. These applications were documented in 17th- and 18th-century ethnobotanical records, highlighting the resin's role in traditional healing practices across boreal regions.

The bark was also widely used by First Nations in a decoction or as an infusion for internal problems such as tuberculosis or diarrhea. The Ojibwa used the fir resin added to tallow or fat to make a pitch to seal their canoes.

Indigenous Nations including the Nuxalk, Haisla, and Kitasoo used Abies amabilis (Pacific silver fir) for medicinal purposes. Ethnobotanist Daniel Moerman notes, for example, that Nuxalk peoples mixed mountain goat tallow with liquid pitch to treat sore throat. An infusion of bark may have been used to address stomach issues. In addition to medicinal uses, hardened pitch of the plant was sometimes chewed for pleasure by the Ditidaht peoples.

European Traditional Medicine (Silver Fir, Abies alba)

European species of pines, spruces, and firs have been widely used as sources of topical antiseptics, salves for burns, rubs and baths for rheumatism, and for preparations to ease bronchial complaints and infections, including teas and the inhalation of vapours.

The leaves are considered expectorant and a bronchial sedative, best harvested in spring and dried for later use. The resin has been described as antiseptic, balsamic, diuretic, eupeptic, expectorant, vasoconstrictor, and vulnerary. Both the leaves and resin are common ingredients in remedies for colds and coughs, either taken internally or used as an inhalant. In folk medicine, the leaves and/or resin are used to treat bronchitis, cystitis, leucorrhoea, ulcers, and flatulent colic.

The resin has also been used externally in bath extracts and rubbing oils for treating rheumatic pains and neuralgia. The buds are considered antibiotic, antiseptic, and balsamic; the bark is described as antiseptic and astringent.

The medieval abbess and herbalist Hildegard von Bingen is cited in traditional records as having used balsam fir preparations. First Nations, the Sisters of Providence, and the famous Hildegard von Bingen used the balsam fir to treat cuts, ulcers, rheumatism, kidney pain, chronic respiratory ailments, and as a tonic.

Himalayan and South Asian Tradition

The Himalayan silver fir (Abies spectabilis, known as Thalis patram in traditional South Asian medicine) is a large tree growing to 50 meters, commonly found in the Himalayan region up to 3000 meters altitude. Its traditional medicinal uses include treatment of cough problems and throat disorders; its chemical contents include betuloside, abioflavonoid, abiesin, β-sitosterol, and abietane, with reported medicinal properties of antiplasmodial, antifungal, and antibacterial activity.

3. Key Constituents and Active Compounds

Essential Oils

Abies alba's essential oil variability is impressive, even among specimens collected from the same geographical area. For essential oils prepared from needles or twigs and branches, limonene, β-pinene, α-pinene, camphene, β-phellandrene, and bornyl acetate are the leading compounds, with wide variations that appear to correspond to multiple chemotypes.

One characterization by GC-MS of a silver fir essential oil sample found bornyl acetate (30.31%), camphene (19.81%), 3-carene (13.85%), tricyclene (12.90%), dl-limonene (7.50%), α-pinene (2.87%), caryophyllene (2.18%), β-phellandrene (2.13%), borneol (1.74%), and α-terpinene (1.24%) as major components. Composition varies substantially by plant part: The volatile composition of Abies alba seeds and cone scales has been studied, identifying 90 volatile constituents; the major component of the seed essential oil was (−)-limonene (about 70%), while that of the cone scale oil was α-pinene (57%), and monoterpene hydrocarbons were predominant in both oils.

For balsam fir (Abies balsamea), the essential oil is essentially constituted of monoterpenes (>96%) and some sesquiterpenes, with β-pinene (29.9%), δ-3-carene (19.6%), and α-pinene (14.6%) as major components.

Polyphenols

Abies alba has aroused interest in phytochemistry in at least three major directions: essential oils contained in multiple parts of the plant; polyphenols (particularly in the bark); and lignans (especially in the bark and wood).

Six phenolic acids have been identified in the bark extract Abigenol®: gallic, homovanillic, protocatechuic, p-hydroxybenzoic, vanillic, and p-coumaric acids, along with three flavonoids (catechin, epicatechin, and catechin tetramethyl ether) and four lignans.

In coniferous biomass including Abies alba, (+)-catechin, epicatechin, rutin, myricetin, 4-hydroxybenzoic and p-coumaric acids, kaempherol, and apigenin were among the main quantified polyphenols, alongside numerous phenolic acids, flavonoids, stilbenes, terpenes, lignans, secoiridoids, and indanes with antioxidant, antimicrobial, anti-inflammatory, antihemolytic, and anti-carcinogenic potential.

Lignans

Both bark and wood of Abies alba are rich in lignans and phenolic compounds. Matairesinol is apparently the dominant lignan in bark, and secoisolariciresinol and lariciresinol are the dominant ones in wood samples. More specifically, the bark, wood, and particularly branches of Abies alba are rich in antioxidative polyphenols among which lignans — taxiresinol, 7-(2-methyl-3,4-dihydroxytetrahydropyran-5-yloxy)-taxiresinol, secoisolariciresinol, laricinresinol, hydroxymatairesinol, isolariciresinol, matairesinol, and pinoresinol — are the most characteristic.

Over 277 bioactive compounds have been identified in silver fir species, including a variety of polyphenols, terpenes, and terpenoids that contribute to the plant's protective functions and potential health benefits.

Diterpenes and Other Constituents

A total of 277 compounds have been isolated from 19 plants of Abies species overall; the chemical constituents are mostly terpenoids, flavonoids, and lignans, together with minor constituents of phenols, steroids, and others. Extractable non-structural compounds in the bark of silver fir include soluble carbohydrates, terpenes, aliphatic alcohols and fatty acids, and polyphenols such as stilbenes, flavonoids, lignans, and tannins.

4. Mechanisms of Action

Antioxidant Activity

The antioxidant activity of fir preparations has been attributed primarily to their polyphenolic content and to specific terpene components. Limonene exerted strong DPPH radical-scavenging activity (93.1%) and mild ABTS radical activity (12.4%), while β-pinene showed medium DPPH radical-scavenging activity (21.4%); α-pinene exerted very low scavenging for both radicals.

Belinal® has demonstrated in vitro antioxidant effects similar to those of epigallocatechin gallate and superior to those of resveratrol, ascorbic acid, or butylated hydroxytoluene. The antioxidant activity of silver fir (Abies alba) bark extract Abigenol® has been shown to be higher than that of maritime pine bark extract in cultured cells.

Enzyme Inhibition (Antidiabetic Mechanisms)

Silver fir wood and bark extracts have been shown to be effective inhibitors of α-glucosidase, α-amylase, and dipeptidyl peptidase 4, three enzymes involved in the regulation of blood glucose levels, in vitro. The extracts potently inhibited key carbohydrate-metabolizing enzymes and attenuated oxidative stress by suppressing ROS production under hyperglycemic conditions; the antidiabetic activity was attributed to lignans, although other components also contribute.

Anti-inflammatory and Antimicrobial Mechanisms

α-Pinene, a prominent constituent of fir essential oils, exhibits significant anti-inflammatory activity, as evidenced by its efficacy in carrageenan- or prostaglandin E-induced rat hind paw edema models and TPA-induced ear edema.

For antimicrobial activity, constituent-level testing of Abies balsamea essential oil identified that β-pinene and δ-3-carene were found inactive against both tested bacterial strains; however, three constituents of the essential oil were active against S. aureus: α-pinene, β-caryophyllene, and α-humulene with MIC values of 13.6 µg/mL, 5.1 µg/mL, and 2.6 µg/mL, respectively.

Cardiovascular and Lipid-Related Mechanisms

By using in vitro hepatic, cardiac, and vascular models, Abigenol®/AlbiPhenol® showed effective antioxidant action and was able to inhibit LDL and HDL oxidation, main actors in atherosclerotic plaque formation. In steatotic conditions, it induced decreased lipid and cholesterol accumulation in hepatocytes. In a cardiac model, the formulation reduced the activity of the hypertension-related angiotensin-converting enzyme (ACE).

5. Scientific Evidence by Area of Use

5.1 Antioxidant and Cytoprotection

The antioxidant properties of Abies alba preparations have been extensively evaluated in laboratory settings. MTT assay results indicated that silver fir essential oil showed no cytotoxic effect at concentrations of 1% and 5% for as long as 24 and 3 hours, respectively.

A 2025 study in Pharmaceutical Biology compared extraction methods for Abies alba: The subcritical water extraction bark extract at 100°C (SWE-BA-100) showed the highest total polyphenol content (73.8 mg GAE/g), lignan content (secoisolariciresinol 204.7 µg/mL), and antioxidant activity (DPPH: 24.2, ABTS: 32.0 mg GAE/g); bark extracts had superior bioactive profiles compared to branch extracts, and all extracts were non-cytotoxic.

Strength of evidence: Antioxidant activity is well-established at the in vitro level across multiple assays (DPPH, ABTS) and cell lines. No large-scale human clinical trials specifically measuring antioxidant outcomes have been published.

5.2 Blood Glucose Regulation and Antidiabetic Activity

In vitro evidence: Silver fir wood and bark extracts were studied to elucidate the in vitro mechanism of anti-diabetic activity and were tested for inhibitory activity of enzymes involved in blood glucose regulation; they were shown to be effective inhibitors of α-glucosidase, α-amylase, and dipeptidyl peptidase 4.

Human clinical evidence: Anti-diabetic properties were shown in a double-blind study of 31 healthy individuals, where Belinal® lowered the glucose concentration in the blood after a meal by 35%. In several pharmacological, toxicological, and clinical studies, the extract has been shown to prevent atherosclerosis in guinea pigs and to have a cardioprotective effect in isolated rat hearts; it was found to reduce the post-prandial glycaemic response in healthy volunteers.

In in vitro studies on HepG2 liver cells using an oleic acid-induced hepatic steatosis model, the Abies alba bark extract Abigenol®/AlbiPhenol® significantly reduced lipid accumulation and cholesterol levels in hepatocytes at a concentration of 1200 µg/mL.

Strength of evidence: Preliminary. The double-blind human study (n=31) is small and short-term and involved healthy volunteers rather than diabetic patients. In vitro enzyme inhibition data are supportive but not sufficient alone to confirm clinical benefit.

5.3 Antimicrobial Activity

The antibacterial activity of the essential oil of Abies balsamea was evaluated against Escherichia coli and Staphylococcus aureus; the essential oil was found to be inactive against E. coli (>100 µg/mL) and active against S. aureus with an MIC of 56 µg/mL.

The seed and cone essential oils of both Abies alba and Abies koreana exhibited DPPH-radical-scavenging properties and low antibacterial activity against the bacterial strains tested.

A 2023 PubMed-indexed study demonstrated that bacterial cellulose membranes loaded with fir needle essential oil inhibited the adhesion of Staphylococcus aureus and Escherichia coli; antibacterial tests on membranes loaded with fir needle essential oil demonstrated the ability of these membranes to inhibit bacterial adhesion to the substrate.

The Abies alba needle extract was more toxic to microbial strains than the eukaryotic cells that provide its active wound healing principles, suggesting a potentially favorable therapeutic index for topical wound applications.

Strength of evidence: Preliminary; restricted to in vitro and materials science studies. No controlled clinical trials in humans evaluating fir preparations as antimicrobial agents have been published.

5.4 Cardiovascular Effects

A novel silver fir (Abies alba) bark extract, Abigenol®/AlbiPhenol®, was studied; its cytotoxicity, bioaccessibility, and bioavailability were evaluated using an in vitro digestion model — the extract was shown to be non-cytotoxic and showed good bioaccessibility. By using in vitro hepatic, cardiac, and vascular models, its antioxidant and anti-steatotic properties were assessed, and it was able to inhibit LDL and HDL oxidation.

Extracts of silver fir wood and bark with high polyphenol content have been shown to have anti-atherosclerotic and cardioprotective properties in animal and in vitro models, respectively. No influence on liver and kidney function was found in toxicological assessments.

Strength of evidence: Preliminary. Findings are from in vitro and animal models; prospective human cardiovascular outcome studies have not been published.

5.5 Musculoskeletal and Joint Health

Investigators studied the effects of two polyphenolic extracts (Belinal® and Pycnogenol) and two polyphenols (resveratrol and quercetin) on the chondrogenic potential of bone-derived mesenchymal stem/stromal cells from healthy donors and patients with osteoarthritis; their main aim was to determine whether Belinal®, a commercially available polyphenolic extract from silver fir branches, has comparable chondrogenic potential with the other compounds. In the study, Belinal® promoted significantly greater chondrogenesis compared to the untreated group (p=0.0289) and resveratrol-treated group (p=0.0468) of MSCs from patients with hip osteoarthritis under non-inflammatory conditions.

Strength of evidence: Very preliminary; findings are from a cell-culture (in vitro) study only. No clinical human trials of fir extract for musculoskeletal disease have been identified.

5.6 Skin Health and Anti-psoriatic Activity

Topical use of the silver fir bark extract Abigenol®/AlbiPhenol® improved skin appearance and function in studied subjects. Pharmacological studies with promising results have evaluated the anti-psoriatic activity of Abies alba preparations.

Strength of evidence: Preliminary; the anti-psoriatic data originate from limited published studies; the skin appearance claim is not derived from a full clinical trial description in the available evidence.

5.7 Respiratory Support

The essential oil of silver fir (Abies alba) is known in traditional and aromatic medicine to help the respiratory system and have an easing and soothing effect on muscle. The antiradical and anti-inflammatory properties of monoterpenes such as limonene and α-pinene present in fir essential oils are considered potentially relevant to respiratory health, though direct human clinical evidence for respiratory outcomes from fir-specific essential oil therapy is limited in the peer-reviewed literature.

Strength of evidence: Traditional use and in vitro mechanistic data exist; rigorous human clinical trials for respiratory outcomes specifically with fir essential oil are not yet available in the peer-reviewed record.

5.8 Antitumor Activity

Crude extracts and metabolites of Abies species have been found to possess antitumor bioactivity among other activities in the reviewed phytochemical literature. The seed and cone essential oils of Abies alba and A. koreana evoked only low cytotoxicity towards normal fibroblasts and two cancer cell lines MCF-7 and MDA-MBA-231.

Strength of evidence: Preclinical (in vitro) only; no clinical evidence for antitumor applications of fir preparations in humans has been established.

6. Body Systems and Health Areas of Association

Respiratory system: Expectorant and bronchial sedative actions attributed to fir needle preparations; inhalation use for coughs and colds.
Musculoskeletal system: Traditional and in vitro data for rheumatic pain, muscle soreness, and early chondrogenic support.
Cardiovascular system: In vitro and animal data for anti-atherosclerotic, cardioprotective, LDL oxidation inhibition, and ACE inhibitory effects.
Metabolic/endocrine system: In vitro enzyme inhibition and one small human study for post-prandial blood glucose modulation.
Skin and integument: Traditional antiseptic and vulnerary use of resin; in vitro and limited clinical data for skin appearance and anti-psoriatic action.
Immune/antimicrobial: In vitro evidence for activity against S. aureus and other organisms from essential oil components.
Antioxidant/general cellular protection: Well-characterized in vitro antioxidant activity across multiple species and plant parts.

7. Dosage Forms and Reported Dosages

Standardized dosage information specifically for fir preparations is limited in the human clinical trial literature. The following reflects what has been reported in the identified sources:

Essential oil (topical dilution): One practical reference describes topical massage application of 1–2 drops of fir needle essential oil mixed with a carrier oil in a 1:1 ratio, applied topically to the affected area.
Bark/wood polyphenol extracts (oral): The Belinal® extract was evaluated in a human pharmacodynamic study reported at a dose used prior to a standardized meal; the specific dose per the available abstract data was not stated in the sources retrieved. The extract was standardized and administered acutely in the 31-subject crossover study.
Silver fir trunk extract (SFTE/Abigenol®): A silver fir trunk extract (SFTE) has been prepared using water as an extraction solvent (DER 100:1) and standardized in protocatechuic acid (7.7 g/L) and p-coumaric acid (3.7 g/L).
In vitro reference concentration: The bark extract Abigenol®/AlbiPhenol® was studied at a concentration of 1200 µg/mL in hepatocyte models.
Essential oil cytotoxicity threshold: The essential oil showed no cytotoxic effect at concentrations of 1% and 5% for up to 24 and 3 hours, respectively, in human fibroblast assay.

No established effective human oral or inhalation dosages for fir essential oil or extracts have been confirmed through adequately powered clinical trials.

8. Safety Considerations and Notable Interactions

Skin Sensitization from Essential Oil Components

Silver fir essential oil is considered non-toxic, non-irritant, and non-sensitizing in its fresh, unoxidized form; however, oxidized oil can cause skin sensitization, and proper storage is recommended to prevent oxidation.

In reported cases of multiple allergies to essential oils in professional aromatherapists, alpha- and beta-pinene — both major components of fir oils — were found to be key allergens; alpha-pinene was confirmed as an allergen on repeat patch testing with pure alpha-pinene in both cases.

Because of the similarities in the chemical structure of many essential oils and fragrances, co-sensitization is common, with frequent positive patch test reactions to fragrance mixes.

Acute Toxicity of Pinene-Based Oils

The literature contains clinical reports of accidental and intentional acute poisoning with pinene-based turpentine. Rat oral LD50 values for alpha-pinene, beta-pinene, camphene, and turpentine oil indicate these materials to be very low in oral acute toxicity with LD50 values in the range of 3388 mg/kg to greater than 5000 mg/kg.

Hepatic and Renal Safety of Polyphenol Extracts

No influence on liver and kidney function was found in the pharmacological and toxicological evaluation of the Belinal®/Abigenol® preparations. Abigenol®/AlbiPhenol® was shown to be non-cytotoxic and showed good bioaccessibility in the in vitro digestion model studied.

Lignan Content and Cellular Behavior

All Abies alba extracts evaluated were non-cytotoxic; however, the SWE bark extract with the highest lignan content inhibited cell migration, indicating a complex interaction between composition and cellular response that warrants further characterization.

General Essential Oil Safety Considerations

Essential oils are typically administered as oil solutions or incorporated into topical preparations, which can sometimes cause skin irritation, erythema, and allergic reactions. While topical application is generally safe for certain essential oils, higher doses or ingestion may lead to skin irritation and contact sensitization.

No documented drug–herb pharmacokinetic or pharmacodynamic interactions specific to fir essential oil or standardized fir extracts were identified in the sources searched. The inhibition of α-glucosidase, α-amylase, and DPP-4 by fir bark/wood extracts in vitro raises a theoretical consideration for additive blood-glucose-lowering effects if used concurrently with antidiabetic medications, though no clinical interaction data were identified.

References

Health Conditions

Health conditions that Fir may help support.

No conditions available.

Body Systems

Body systems that Fir may help support.

No body systems available.